Virrey, Michelle B.
HRN: 26-48-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2026
AMPICILLIN 1GM (VIAL)
02/01/2026
02/03/2026
IVTT
2g
Q6h
PROMx 4hours; Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes